Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Biogen introduces Avonex in first market

May 24, 1996

ICN will market fluoxetine in Russia, ex-Yugoslavia

May 24, 1996

Fujisawa, Nihon Shokubai claim CCK-B antagonists

May 24, 1996

ADIR claims melatonin receptor ligands for CNS disorders

May 24, 1996

Ultiva okayed for marketing in Germany; U.S. approval recommended by committee

May 24, 1996

Rizatriptan NDA filing expected in mid-1997

May 24, 1996

L-742694: Morpholine-based NK1 antagonist

May 24, 1996

CP-122721 shows potent affinity for NK1 receptors after oral dosing

May 24, 1996

Myotrophin up for advisory committee review

May 17, 1996

Memantine to be tested in AIDS-related dementia, painful peripheral neuropathies

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 14, 2025.
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld Science
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
Anchoring, and bootstrapping, psychiatry into the precision medicine era
BioWorld Science
Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...